Five Prime Therapeutics' IPO

Five Prime Therapeutics raised a round of funding on September 18, 2013. Investors include Public.

Five Prime Therapeutics is a clinical-stage biotechnology company with a pipeline of antibodies and ligand traps for cancer, autoimmunity and respiratory diseases. FivePrime has differentiated discove…

Articles about Five Prime Therapeutics' IPO: